Default company panoramic image
70a1b8dd b29d 4b81 9a82 a5bfc8aacc9a


we aim to leverage int cardiology skills and technology to radically improve outcomes for sufferers of pulmonary arterial hypertension

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Galway, Ierland
  • Currency EUR
  • Founded August 2011
  • Employees 2

Company Summary

\our customers are patients and their doctors who suffer from this terrible and debilating disease called Pulmonary Atrial Hypertension.
In conjunction with a leading team of doctors have designed device to alleviate some of the more debilating side effects of this disease. This will improve the patients quality of life and life span.


  • Default avatar
    Michael Gilmore

    Chief Executive Officer of Alleviate.

    General Manager and VP of R&D at Cappella Medical Devices Ltd. Previously worked at Boston Scientific Corporation, EV3, and SteriPack B.Sc. in Polymer Technology from Athlone Institute of Technology. Diploma in Accounting